View of 1068 – Adjuvant capecitabine in residual triplenegative breast cancer after carboplatin-based neoadjuvant chemotherapy: a real-world cohort

Return to Article Details 1068 – Adjuvant capecitabine in residual triplenegative breast cancer after carboplatin-based neoadjuvant chemotherapy: a real-world cohort Download Download PDF